{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:20:45Z","timestamp":1790889645147,"version":"4.1.0"},"reference-count":28,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11,1]]},"abstract":"<jats:p>OBJECTIVE. Our goal was to determine whether, for preterm newborn infants with respiratory disease, inhaled nitric oxide reduced the rates of death, bronchopulmonary dysplasia, intracranial hemorrhage, or neurodevelopmental disability.<\/jats:p>\n               <jats:p>METHODS. We searched Medline, Embase, Healthstar, and the Cochrane Central Register of Controlled Trials using the search terms \u201cnitric oxide,\u201d \u201cclinical trial,\u201d and \u201cnewborn\u201d and covering 1985\u20132006. We also searched abstracts of the Pediatric Academic Societies.<\/jats:p>\n               <jats:p>RESULTS. Eleven randomized, controlled trials of inhaled nitric oxide therapy for preterm infants were found. The trials were grouped into 3 categories according to the entry criteria, that is, entry in the first 3 days of life on the basis of oxygenation criteria (early rescue), enrollment after 3 days on the basis of elevated risk of bronchopulmonary dysplasia, and routine use for intubated preterm infants. Early rescue treatment based on oxygenation criteria did not seem to affect mortality or bronchopulmonary dysplasia rates. Routine use for intubated preterm infants showed a barely significant reduction in the incidence of the combined outcome of death or bronchopulmonary dysplasia (relative risk [RR]: 0.91 [95% confidence limits (CLs): 0.84, 0.99]). Later treatment based on the risk of bronchopulmonary dysplasia showed no significant effect on this outcome. Early rescue treatment showed a trend toward increased incidence of severe intracranial hemorrhage, whereas routine use for intubated preterm infants seemed to show a reduction in the incidence of either severe intracranial hemorrhage or periventricular leukomalacia (RR: 0.70 [95% CLs: 0.53, 0.91]).<\/jats:p>\n               <jats:p>CONCLUSIONS. Inhaled nitric oxide as rescue therapy for very ill preterm infants undergoing ventilation does not seem to be effective and may increase severe intracranial hemorrhage. Later use of inhaled nitric oxide to prevent bronchopulmonary dysplasia does not seem to be effective. Early routine use of inhaled nitric oxide for mildly sick, preterm infants seems to decrease the risk of serious brain injury and may improve rates of survival without bronchopulmonary dysplasia.<\/jats:p>","DOI":"10.1542\/peds.2007-0726","type":"journal-article","created":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T17:08:45Z","timestamp":1193936925000},"page":"1088-1099","source":"Crossref","is-referenced-by-count":49,"title":["Inhaled Nitric Oxide for Preterm Infants: A Systematic Review"],"prefix":"10.1542","volume":"120","author":[{"given":"Keith J.","family":"Barrington","sequence":"first","affiliation":[{"name":"Department of Pediatrics, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil N.","family":"Finer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2007,11,1]]},"reference":[{"key":"2022050910562708000_R1","doi-asserted-by":"crossref","unstructured":"Horbar JD, Badger GJ, Carpenter JH, et al. Trends in mortality and morbidity for very low birth weight infants, 1991\u20131999. Pediatrics.\u20082002;110:143\u2013151","DOI":"10.1542\/peds.110.1.143"},{"key":"2022050910562708000_R2","doi-asserted-by":"crossref","unstructured":"Schmidt B, Asztalos EV, Roberts RS, Robertson CM, Sauve RS, Whitfield MF. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA.\u20082003;289:1124\u20131129","DOI":"10.1001\/jama.289.9.1124"},{"key":"2022050910562708000_R3","doi-asserted-by":"crossref","unstructured":"Skimming JW, DeMarco VG, Cassin S. The effects of nitric oxide inhalation on the pulmonary circulation of preterm lambs. Pediatr Res.\u20081995;37:35\u201340","DOI":"10.1203\/00006450-199501000-00008"},{"key":"2022050910562708000_R4","doi-asserted-by":"crossref","unstructured":"Kinsella JP, Ivy DD, Abman SH. Inhaled nitric oxide improves gas exchange and lowers pulmonary vascular resistance in severe experimental hyaline membrane disease. Pediatr Res.\u20081994;36:402\u2013408","DOI":"10.1203\/00006450-199409000-00022"},{"key":"2022050910562708000_R5","doi-asserted-by":"crossref","unstructured":"Walther FJ, Benders MJ. Persistent pulmonary hypertension in premature neonates with severe respiratory distress syndrome. Pediatrics.\u20081992;90:899\u2013904","DOI":"10.1542\/peds.90.6.899"},{"key":"2022050910562708000_R6","doi-asserted-by":"crossref","unstructured":"Finer NN, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev.\u20082006;(4):CD000399","DOI":"10.1002\/14651858.CD000399.pub2"},{"key":"2022050910562708000_R7","doi-asserted-by":"crossref","unstructured":"Vohr BR, Wright LL, Poole WK, McDonald SA, NICHD Neonatal Research Network Follow-up Study. Neurodevelopmental outcomes of extremely low birth weight infants &lt;32 weeks\u2019 gestation between 1993 and 1998. Pediatrics.\u20082005;116:635\u2013643","DOI":"10.1542\/peds.2004-2247"},{"key":"2022050910562708000_R8","doi-asserted-by":"crossref","unstructured":"Wood NS, Costeloe K, Gibson AT, et al. The EPICure study: associations and antecedents of neurological and developmental disability at 30 months of age following extremely preterm birth. Arch Dis Child Fetal Neonatal Ed.\u20082005;90:F134\u2013F140","DOI":"10.1136\/adc.2004.052407"},{"key":"2022050910562708000_R9","doi-asserted-by":"crossref","unstructured":"McAndrew J, Patel RP, Jo H, et al. The interplay of nitric oxide and peroxynitrite with signal transduction pathways: implications for disease. Semin Perinatol.\u20081997;21:351\u2013366","DOI":"10.1016\/S0146-0005(97)80002-X"},{"key":"2022050910562708000_R10","doi-asserted-by":"crossref","unstructured":"Hogman M, Frostell C, Arnberg H, Hedenstierna G. Bleeding time prolongation and NO inhalation. Lancet.\u20081993;341:1664\u20131665","DOI":"10.1016\/0140-6736(93)90802-N"},{"key":"2022050910562708000_R11","doi-asserted-by":"crossref","unstructured":"Samama C, Diaby M, Fellahi J, et al. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology.\u20081995;83:56\u201365","DOI":"10.1097\/00000542-199507000-00007"},{"key":"2022050910562708000_R12","doi-asserted-by":"crossref","unstructured":"Peliowski A, Finer N, Etches P, Tierney A, Ryan C. Inhaled nitric oxide for premature infants after prolonged rupture of the membranes. J Pediatr.\u20081995;126:450\u2013453","DOI":"10.1016\/S0022-3476(95)70467-1"},{"key":"2022050910562708000_R13","doi-asserted-by":"crossref","unstructured":"Abman SH, Kinsella JP, Schaffer MS, Wilkening RB. Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress and pulmonary hypertension. Pediatrics.\u20081993;92:606\u2013609","DOI":"10.1542\/peds.92.4.606"},{"key":"2022050910562708000_R14","doi-asserted-by":"crossref","unstructured":"Kinsella JP, Walsh WF, Bose CL, et al. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial. Lancet.\u20081999;354:1061\u20131065","DOI":"10.1016\/S0140-6736(99)03558-8"},{"key":"2022050910562708000_R15","doi-asserted-by":"crossref","unstructured":"Hascoet JM, Fresson J, Claris O, et al. The safety and efficacy of nitric oxide therapy in premature infants. J Pediatr.\u20082005;146:318\u2013323","DOI":"10.1016\/j.jpeds.2004.10.019"},{"key":"2022050910562708000_R16","doi-asserted-by":"crossref","unstructured":"Field D, Elbourne D, Truesdale A, et al. Neonatal Ventilation With Inhaled Nitric Oxide Versus Ventilatory Support Without Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure: the INNOVO Multicentre Randomised Controlled Trial (ISRCTN 17821339). Pediatrics.\u20082005;115:926\u2013936","DOI":"10.1542\/peds.2004-1209"},{"key":"2022050910562708000_R17","doi-asserted-by":"crossref","unstructured":"Van Meurs KP, Wright LL, Ehrenkranz RA, et al. Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med.\u20082005;353:13\u201322","DOI":"10.1056\/NEJMoa043927"},{"key":"2022050910562708000_R18","doi-asserted-by":"crossref","unstructured":"Mercier J, Theboud B, Onody P, Storme L, van Overmeire B, Breart G. Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial. Lancet.\u20081999;354:1\u201313","DOI":"10.1016\/S0140-6736(99)03309-7"},{"key":"2022050910562708000_R19","doi-asserted-by":"crossref","unstructured":"Dani C, Bertini G, Pezzati M, Filippi L, Cecchi A, Rubaltelli F. Inhaled nitric oxide in very preterm infants with severe respiratory distress syndrome. Acta Paediatr.\u20082006;95:1116\u20131123","DOI":"10.1080\/08035250600702594"},{"key":"2022050910562708000_R20","unstructured":"Srisuparp P, Heitschmidt M, Schreiber MD. Inhaled nitric oxide therapy in premature infants with mild to moderate respiratory distress syndrome. J Med Assoc Thai.\u20082002;85(suppl 2):S469\u2013S478"},{"key":"2022050910562708000_R21","doi-asserted-by":"crossref","unstructured":"Martin RJ, Walsh MC. Inhaled nitric oxide for preterm infants: who benefits?N Engl J Med.\u20082005;353:82\u201384","DOI":"10.1056\/NEJMe058124"},{"key":"2022050910562708000_R22","doi-asserted-by":"crossref","unstructured":"Kinsella JP, Cutter GR, Walsh WF, et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med.\u20082006;355:354\u2013364","DOI":"10.1056\/NEJMoa060442"},{"key":"2022050910562708000_R23","doi-asserted-by":"crossref","unstructured":"Subhedar N, Ryan S, Shaw N. Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants. Arch Dis Child Fetal Neonatal Ed.\u20081997;77:F185\u2013F190","DOI":"10.1136\/fn.77.3.F185"},{"key":"2022050910562708000_R24","doi-asserted-by":"crossref","unstructured":"Ballard RA, Truog WE, Cnaan A, et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med.\u20082006;355:343\u2013353","DOI":"10.1056\/NEJMoa061088"},{"key":"2022050910562708000_R25","doi-asserted-by":"crossref","unstructured":"Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics.\u20081975;31:103\u2013115","DOI":"10.2307\/2529712"},{"key":"2022050910562708000_R26","doi-asserted-by":"crossref","unstructured":"Ryan S, Nyeyk J, Shaw B. Prediction of chronic neonatal lung disease on day 4 of life. Eur J Pediatr.\u20081996;155:668\u2013671","DOI":"10.1007\/BF01957150"},{"key":"2022050910562708000_R27","doi-asserted-by":"crossref","unstructured":"Mestan KKL, Marks JD, Hecox K, Huo D, Schreiber MD. Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. N Engl J Med.\u20082005;353:23\u201332","DOI":"10.1056\/NEJMoa043514"},{"key":"2022050910562708000_R28","doi-asserted-by":"crossref","unstructured":"Bennett AJ, Shaw NJ, Gregg JE, Subhedar NV. Neurodevelopmental outcome in high-risk preterm infants treated with inhaled nitric oxide. Acta Paediatr.\u20082001;90:573\u2013576","DOI":"10.1080\/080352501750197746"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/5\/1088\/1031788\/zpe01107001088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/120\/5\/1088\/1031788\/zpe01107001088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T10:56:37Z","timestamp":1652093797000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/120\/5\/1088\/71121\/Inhaled-Nitric-Oxide-for-Preterm-Infants-A"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,1]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,11,1]]},"published-print":{"date-parts":[[2007,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-0726","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,1]]}}}